Clinical Trials
27 trialsNCT06438705 2025-03-11
99mTc Labeled FAP Targeted Molecular Probe in Early Diagnosis of Tumors
Nanjing First Hospital, Nanjing Medical University
Unknown
NCT06363123 2024-04-15
Plasma Metabolic Biomarkers for Multi-Cancer Diagnosis
Beijing Friendship Hospital
Unknown
NCT06321640 2024-03-20
POSITive
European Institute of Oncology
Unknown
NCT05872867 2024-03-12
MK-3475-E90
Wellmarker Bio
Phase 1 Unknown
NCT06307093 2024-03-12
Study Comparing the Pharmacokinetics, Safety, and Efficacy of RPH-075 and Keytruda® in Patients With Malignant Neoplasms
R-Pharm
Phase 1 Unknown
NCT06152419 2024-01-05
Patient Education Videos to Improve Patients' Experience During Radiotherapy Treatment: a National Project
University Hospital, Ghent
Phase NA Unknown
NCT05837598 2023-08-03
Adapting the Tumor Board Model for Mental Illness and Cancer
Massachusetts General Hospital
Phase NA Unknown
NCT05708950 2023-07-13
A Clinical Trial of KVA12123 Treatment Alone and in Combination With Pembrolizumab In Advanced Solid Tumors (VISTA-101)
Kineta Inc.
Phase 1/2 Unknown
NCT05886075 2023-06-02
A Clinical Study on Oncolytic Virus Injection (R130) for the Treatment of Relapsed/Refractory Advanced Solid Tumors
Shanghai Yunying Medical Technology
Phase EARLY_PHASE1 Unknown
NCT05685524 2023-01-17
Clinical Study of Pan-cancer DNA Methylation Test in Plasma
Wuhan Ammunition Life-tech Co., Ltd
Unknown
NCT05655663 2022-12-19
IMMUNOVASC
Centre Henri Becquerel
Phase NA Unknown
NCT05227898 2022-10-25
RESTORE
Blue Note Therapeutics
Phase NA Unknown
NCT04801095 2022-09-16
A Phase I Study of WM-S1-030 in Patients With Advanced Solid Tumors
Wellmarker Bio
Phase 1 Unknown
NCT03634982 2022-09-01
Dose Escalation of RMC-4630 Monotherapy in Relapsed/Refractory Solid Tumors
Revolution Medicines, Inc.
Phase 1 Unknown
NCT03934827 2022-08-11
MICROBIOME
Imperial College London
Phase 1 Unknown
NCT05180851 2022-02-01
YSCH-01
Shanghai Fengxian District Central Hospital
Phase EARLY_PHASE1 Unknown
NCT04697446 2021-08-10
External Control, Observational, Retrospective Study Comparing Pralsetinib to Best Available Therapy in Patients With RET-Fusion Positive NSCLC
Blueprint Medicines Corporation
Unknown
NCT03896958 2020-12-04
PIONEER
SpeciCare
Unknown
NCT04476641 2020-07-20
DC-CIK
Sun Yat-sen University
Phase 2 Unknown
NCT04073680 2020-05-21
A Phase 1b/2 Study of Serabelisib in Combination With Canagliflozin in Patients With Advanced Solid Tumors
Petra Pharma
Phase 1/2 Unknown
NCT02837679 2020-04-29
Oncogeriatric Intervention and Follow-up at Home
University of Aarhus
Phase NA Unknown
NCT02292914 2019-08-08
Prospective Analysis of Robot-Assisted Surgery
Instituto do Cancer do Estado de São Paulo
Phase NA Unknown
NCT02433626 2019-02-01
COTI2-101
Critical Outcome Technologies Inc.
Phase 1 Unknown
NCT03047525 2017-02-09
Study of DC-CTL Combined With CIK for Advanced Solid Tumor
Harbin Medical University
Phase 1/2 Unknown
NCT01254591 2013-08-26
Positron Emission Tomography/Computed Tomography Scanning Before Surgery in Patients With Non-Small Cell Lung Cancer, Colorectal Cancer, Breast Cancer, Esophageal Cancer, or Head and Neck Cancer
National Cancer Institute (NCI)
Phase NA Unknown
NCT00710697 2009-09-24
Cardiac Safety Assessment Study of Picoplatin in Solid Tumors
Poniard Pharmaceuticals
Phase 1 Unknown
NCT00687778 2008-06-02
11C-Acetate PET/CT Non-FDG-Avid Tumors
Tel-Aviv Sourasky Medical Center
Unknown